OnDemand - Samir Melki, MD, PhD - Visiting Professor Lecture in Refractive Surgery (NON-CME)

Samir Melki MD PhD is currently an associate professor of ophthalmology at Harvard Medical School. He completed a fellowship in Cornea and Refractive Surgery at the Massachusetts Eye and Ear Infirmary, an MD PhD from Vanderbilt University and an Ophthalmology residency at Georgetown University.

Dr. Melki founded Boston Vision in 2000, an academically-oriented practice. He was the Medical Director for Ophthalmology at the UK Specialist Hospitals in England from 2005 till 2013 where he established and managed quality controls for about 20,000 cataract procedures.

Dr. Melki’s career is highlighted by numerous achievements. He has published 4 textbooks as well as 57 articles in respected peer reviewed scientific journals. Dr Melki  regularly teaches at international scientific meetings where he is often invited to speak. He has received an achievement award from both the American Academy of Ophthalmology and the Mass Eye and Ear Infirmary.  Dr. Melki was the first surgeon to place an implantable contact lens in Boston and was the first person to ever implant a device to wirelessly measure intraocular pressure in a patient with glaucoma.

Dr. Melki has a very active clinical practice. He is the Medical Director of Boston Vision growing it to 8 locations with a staff of 23 doctors and more than 150 employees. He is a prominent surgeon known for his expertise in cataract, corneal and laser eye surgery. He is closely involved in the fellowship program in Cornea and Refractive surgery at Mass and Ear and Boston Vision.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.